← Oncology Approval Tracker

FDA DECISION ·

Yervoy + Opdivo

ipilimumab with nivolumab · Bristol Myers Squibb

FDA approvalNew or expanded indicationMelanoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

The Yervoy label gained an indication for adults with unresectable or metastatic melanoma treated with ipilimumab in combination with nivolumab.

LAMPGEN ANALYSIS

Why it matters

The 2021 action adds the existing checkpoint combination to the ipilimumab label.

What research teams should watch

Record the application and action date independently from the earlier nivolumab label action.

PRIMARY RECORDS

Sources